Looking to publish in European Neuropsychopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowEuropean Neuropsychopharmacology is the official journal of the European College of Neuropsychopharmacology and focuses on clinical and basic science contributions that advance understanding of brain function and human behaviour, with emphasis on translating neuroscience and genomics findings into improved psychiatric treatments and public health impact.
Looking to publish in European Neuropsychopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
European Neuropsychopharmacology accepts the following article types. Click on an article type to view submission instructions.
Full Length Research Papers
Reviews On Specialised Topics
Short Communications
Letters To The Editor
Insights Papers
Recent Publications
Commentary on: The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD
Cleo L. Crunelle, Michiel W. Van Kernebeek, Mathias Luderer
Corrigendum to “Functioning assessment short test for autism (FAST-A): a tool to evaluate adaptive functioning in autistic adults” [European Neuropsychopharmacology, 112, 112887]
Maria Martinez-Ramirez, Laura Gisbert Gustemps, Imanol Setién Ramos, Caterina del Mar Bonnín, Anabel Martínez-Aran, Eduard Vieta, Maria Magan-Maganto, Josep Antoni Ramos-Quiroga, Jorge Lugo Marin
Genomic relationship between polyendocrine metabolic ovarian syndrome and bipolar disorder
Piotr Jaholkowski, Markos Tesfaye, Vera Fominykh, Pravesh Parekh, Erik D Wiström, Nadine Parker, Elise Koch, Anna E. Bauer, Pawel Trzaskoma, Jaroslav Rokicki, Shahram Bahrami, Zillur Rahman, Oleksandr Frei, Srdjan Djurovic, Anders M. Dale, Alexey A. Shadrin, Kevin S. O’Connell, Ole A. Andreassen
Genetic overlap between depression and C-reactive protein levels: Evidence from a cross-trait analysis
Manuel Donato Rodríguez-Romero, Pau Carabí-Gassol, Judit Cabana-Domínguez, Natalia Llonga, Uxue Zubizarreta-Arruti, Marta Graell, Valeria Macias-Chimborazo, Josep Antoni Ramos-Quiroga, Gara Arteaga-Henriquez, Marta Ribasés, Silvia Alemany, María Soler Artigas
Variability in AI-generated psychedelic definitions across major chatbots
Zofia Kachlik, Wiesław Jerzy Cubała, Michał Walaszek
Frequently asked questions
How long does it take to publish?
45 days from submission to decision after review; 33 days from submission to acceptance.
Reformat to European Neuropsychopharmacology using Livewrite PremiumIs a cover letter required?
A covering letter must accompany all submissions.
Reformat to European Neuropsychopharmacology using Livewrite PremiumWhat are the publication costs?
USD 3000 excl. taxes for open access articles; no open access publication fee for subscription articles.
Reformat to European Neuropsychopharmacology using Livewrite Premium